Bendamustine( SDX105 )

Catalog No. M21612 CAS No. 16506-27-7

Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	41	Get Quote
5MG	65	Get Quote
10MG	110	Get Quote
25MG	245	Get Quote
50MG	385	Get Quote
100MG	575	Get Quote
500MG	1233	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Bendamustine
Note

Research use only, not for human use.
Brief Description

Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
Description

Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
In Vitro

——
In Vivo

——
Synonyms

SDX105
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

cancer
Indication

Hodgkin's Disease Lymphoma

Chemical Information

CAS Number

16506-27-7
Formula Weight

358.26
Molecular Formula

C16H21Cl2N3O2
Purity

>98% (HPLC)
Solubility

DMSO:72 mg/mL (200.97 mM)
SMILES

Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks